Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites

Journal of Tropical Medicine

Volumn , Issue , 2012, Pages

  Selvapandiyan, Angamuthu ^a   Dey, Ranadhir ^b   Gannavaram, Sreenivas ^b   Lakhal Naouar, Ines ^b   Duncan, Robert ^b   Salotra, Poonam ^c   Nakhasi, Hira L ^b  

^a Institute of Molecular Medicine   (India)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LEISHMANIA VACCINE; LIVE VACCINE;

DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNITY; IMMUNOLOGICAL MEMORY; LEISHMANIA DONOVANI; MICROBIAL ATTENUATION; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; REINFECTION; REVIEW; TRANSGENIC ORGANISM; VISCERAL LEISHMANIASIS;

EID: 81555195734     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2012/631460     Document Type: Review

References (133)

1. Desjeux P., Leishmaniasis: current situation and new perspectives Comparative Immunology, Microbiology and Infectious Diseases 2004 27 5 305 318 (Pubitemid 38842803)
2. Selvapandiyan A., Duncan R., Mendez J., Kumar R., Salotra P., Cardo L. J., Nakhasi H. L., A Leishmania minicircle DNA footprint assay for sensitive detection and rapid speciation of clinical isolates Transfusion 2008 48 9 1787 1798
3. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R. W., Alvar J., Boelaert M., Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology 2007 5 11 873 882 (Pubitemid 47578388)
4. Herwaldt B. L., Leishmaniasis Lancet 1999 354 9185 1191 1199 (Pubitemid 29460458)
5. Maloney D. M., Maloney J. E., Dotson D., Popov V. L., Sanchez R. L., Cutaneous leishmaniasis: Texas case diagnosed by electron microscopy Journal of the American Academy of Dermatology 2002 47 4 614 616
6. McHugh C. P., Melby P. C., LaFon S. G., Leishmaniasis in Texas: epidemiology and clinical aspects of human cases American Journal of Tropical Medicine and Hygiene 1996 55 5 547 555 (Pubitemid 26392720)
7. Gaskin A. A., Schantz P., Jackson J., Birkenheuer A., Tomlinson L., Gramiccia M., Levy M., Steurer F., Kollmar E., Hegarty B. C., Ahn A., Breitschwerdt E. B., Visceral leishmaniasis in a New York foxhound kennel Journal of Veterinary Internal Medicine 2002 16 1 34 44 (Pubitemid 135746921)
8. Luz K. G., Da Silva V. O., Gomes E. M., Machado F. C. S., Araujo M. A. F., Fonseca H. E. M., Freire T. C., D'Almeida J. B., Palatnik M., Palatnik-De-Sousa C. B., Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients American Journal of Tropical Medicine and Hygiene 1997 57 2 168 171 (Pubitemid 27360607)
9. American Association of Blood Bankers. Deferral for risk of leishmaniasis exposure AABB Bulletin 2003 3 14
10. Giger U., Oakley D. A., Owens S. D., Schantz P., Leishmania donovani transmission by packed RBC transfusion to anemic dogs in the United States Transfusion 2002 42 3 381 383
11. Palatnik-De-Sousa C. B., Paraguai-De-Souza E., Gomes E. M., Soares-Machado F. C., Luz K. G., Borojevic R., Transmission of visceral leishmaniasis by blood transfusion in hamsters Brazilian Journal of Medical and Biological Research 1996 29 10 1311 1315 (Pubitemid 126496898)
12. Sundar S., Chatterjee M., Visceral leishmaniasiscurrent therapeutic modalities Indian Journal of Medical Research 2006 123 3 345 352
13. Pandey B. D., Pandey K., Kaneko O., Yanagi T., Hirayama K., Relapse of visceral leishmaniasis after miltefosine treatment in a nepalese patient American Journal of Tropical Medicine and Hygiene 2009 80 4 580 582
14. Zijlstra E. E., Musa A. M., Khalil E. A. G., El Hassan I. M., El-Hassan A. M., Post-kala-azar dermal leishmaniasis Lancet Infectious Diseases 2003 3 2 87 98 (Pubitemid 36164205)
15. Melby P. C., Ogden G. B., Flores H. A., Zhao W., Geldmacher C., Biediger N. M., Ahuja S. K., Uranga J., Melendez M., Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library Infection and Immunity 2000 68 10 5595 5602
16. Kedzierski L., Zhu Y., Handman E., Leishmania vaccines: progress and problems Parasitology 2006 133 2 S87 S112
17. Palatnik-de-Sousa C. B., Vaccines for leishmaniasis in the fore coming 25 years Vaccine 2008 26 14 1709 1724
18. Fortier A. H., Slayter M. V., Ziemba R., Meltzer M. S., Nacy C. A., Live vaccine strain of Francisella tularensis: infection and immunity in mice Infection and Immunity 1991 59 9 2922 2928
19. Nakhasi H. L., Zheng D., Callahan L., Dave J. R., Liu T. Y., Rubella virus: mechanism of attenuation in the vaccine strain (HPV77) Virus Research 1989 13 3 231 244 (Pubitemid 19191348)
20. Kedzierski L., Leishmaniasis vaccine: where are we today? Journal of Global Infectious Diseases 2010 2 2 177 185
21. Selvapandiyan A., Duncan R., Debrabant A., Lee N., Sreenivas G., Salotra P., Nakhasi H. L., Genetically modified live attenuated parasites as vaccines for leishmaniasis Indian Journal of Medical Research 2006 123 3 455 466 (Pubitemid 43905582)
22. Costa C. H. N., Peters N. C., Maruyama S. R., de Brito E. C. Jr., de Miranda Santos I. K. F., Vaccines for the leishmaniases: proposals for a research agenda PLoS Neglected Tropical Diseases 2011 5 3
23. Handman E., Leishmaniasis: current status of vaccine development Clinical Microbiology Reviews 2001 14 2 229 243 (Pubitemid 32294669)
24. Van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T., Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages Journal of Immunology 2004 173 11 6521 6525 (Pubitemid 39541033)
25. Peters N. C., Egen J. G., Secundino N., Debrabant A., Kimblin N., Kamhawi S., Lawyer P., Fay M. P., Germain R. N., Sacks D., In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies Science 2008 321 5891 970 974
26. Chakraborty D., Banerjee S., Sen A., Banerjee K. K., Das P., Roy S., Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts Journal of Immunology 2005 175 5 3214 3224 (Pubitemid 41170542)
27. Bogdan C., Rllinghoff M., The immune response to Leishmania: mechanisms of parasite control and evasion International Journal for Parasitology 1998 28 1 121 134 (Pubitemid 28082065)
28. Bacellar O., Brodskyn C., Guerreiro J., Barral-Netto M., Costa C. H., Coffman R. L., Johnson W. D., Carvalho E. M., Interleukin-12 restores interferon- production and cytotoxic responses in visceral leishmaniasis Journal of Infectious Diseases 1996 173 6 1515 1518 (Pubitemid 26286820)
29. Bacellar O., D'Oliveira A., Jernimo S., Carvalho E. M., IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis Cytokine 2000 12 8 1228 1231 (Pubitemid 30611800)
30. Engwerda C. R., Murphy M. L., Cotterell S. E. J., Smelt S. C., Kaye P. M., Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani European Journal of Immunology 1998 28 2 669 680 (Pubitemid 28101744)
31. Ghalib H. W., Whittle J. A., Kubin M., Hashim F. A., El-Hassan A. M., Grabstein K. H., Trinchieri G., Reed S. G., IL-12 enhances Th1-type responses in human Leishmania donovani infections Journal of Immunology 1995 154 9 4623 4629
32. Alexander J., Bryson K., T helper (h)1/Th2 and Leishmania: paradox rather than paradigm Immunology Letters 2005 99 1 17 23 (Pubitemid 40718928)
33. Nylén S., Sacks D., Interleukin-10 and the pathogenesis of human visceral leishmaniasis Trends in Immunology 2007 28 9 378 384 (Pubitemid 47385375)
34. Cummings H. E., Tuladhar R., Satoskar A. R., Cytokines and their STATs in cutaneous and visceral leishmaniasis Journal of Biomedicine amp; Biotechnology 2010 2010 6
35. Murphy M. L., Wille U., Villegas E. N., Hunter C. A., Farrell J. P., IL-10 mediates susceptibility to Leishmania donovani infection European Journal of Immunology 2001 31 10 2848 2856 (Pubitemid 32994535)
36. Murray H. W., Moreira A. L., Lu C. M., DeVecchio J. L., Matsuhashi M., Ma X., Heinzel F. P., Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis Journal of Infectious Diseases 2003 188 3 458 464 (Pubitemid 36960658)
37. Nylén S., Maurya R., Eidsmo L., Das Manandhar K., Sundar S., Sacks D., Splenic accumulation of IL-10 mRNA in T cells distinct from CD4 +CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis Journal of Experimental Medicine 2007 204 4 805 817 (Pubitemid 46631610)
38. Kenney R. T., Sacks D. L., Gam A. A., Murray H. W., Sundar S., Splenic cytokine responses in Indian kala-azar before and after treatment Journal of Infectious Diseases 1998 177 3 815 819 (Pubitemid 28099908)
39. Fiorentino D. F., Bond M. W., Mosmann T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones Journal of Experimental Medicine 1989 170 6 2081 20095 (Pubitemid 20010086)
40. Mosmann T. R., Moore K. W., The role of IL-10 in crossregulation of T(H)1 and T(H)2 responses Immunology Today 1991 12 3 A49 A53
41. Bhattacharyya S., Ghosh S., Jhonson P. L., Bhattacharya S. K., Majumdar S., Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events Infection and Immunity 2001 69 3 1499 1507 (Pubitemid 32187601)
42. Vouldoukis I., Bécherel P. A., Riveros-Moreno V., Arock M., Da Silva O., Debré P., Mazier D., Mossalayi M. D., Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation European Journal of Immunology 1997 27 4 860 865 (Pubitemid 27153653)
43. Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R., Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI Science 1990 248 4960 1230 1234
44. Holaday B. J., Pompeu M. M. D. L., Jeronimo S., Texeira M. J., De Queiroz Sousa A., Vasconcelos A. W., Pearson R. D., Abrams J. S., Locksley R. M., Potential role for interleukin-10 in the immunosuppression associated with kala azar Journal of Clinical Investigation 1993 92 6 2626 2632 (Pubitemid 24006526)
45. De Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., De Vries J. E., Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes Journal of Experimental Medicine 1991 174 5 1209 1220
46. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M., Sacks D. L., CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity Nature 2002 420 6915 502 507 (Pubitemid 35477041)
47. Stger S., Maroof A., Zubairi S., Sanos S. L., Kopf M., Kaye P. M., Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells European Journal of Immunology 2006 36 7 1764 1771 (Pubitemid 44089043)
48. Cua D. J., Stohlman S. A., In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets Journal of Immunology 1997 159 12 5834 5840 (Pubitemid 127471517)
49. Lehn M., Weiser W. Y., Engelhorn S., Gillis S., Remold H. G., IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN- Journal of Immunology 1989 143 9 3020 3024 (Pubitemid 19281854)
50. Alexander J., Christine Carter K., Al-Fasi N., Satoskar A., Brombacher F., Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis European Journal of Immunology 2000 30 10 2935 2943
51. Dey R., Majumder N., Majumdar S. B., Bhattacharjee S., Banerjee S., Roy S., Majumdar S., Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice Scandinavian Journal of Immunology 2007 66 6 671 683 (Pubitemid 350132638)
52. Dey R., Khan S., Pahari S., Srivastava N., Jadhav M., Saha B., Functional paradox in host-pathogen interaction dictates the fate of parasites Future Microbiology 2007 2 4 425 437 (Pubitemid 47365027)
53. Selvapandiyan A., Dey R., Nylen S., Duncan R., Sacks D., Nakhasi H. L., Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis Journal of Immunology 2009 183 3 1813 1820
54. Banerjee A., De M., Ali N., Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses Journal of Immunology 2008 181 2 1386 1398
55. Murray H. W., Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis Journal of Infectious Diseases 1997 175 6 1477 1479 (Pubitemid 27225053)
56. Mege J. L., Meghari S., Honstettre A., Capo C., Raoult D., The two faces of interleukin 10 in human infectious diseases Lancet Infectious Diseases 2006 6 9 557 569 (Pubitemid 44262343)
57. Jankovic D., Kullberg M. C., Feng C. G., Goldszmid R. S., Collazo C. M., Wilson M., Wynn T. A., Kamanaka M., Flavell R. A., Sher A., Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection Journal of Experimental Medicine 2007 204 2 273 283 (Pubitemid 46294544)
58. Anderson C. F., Oukka M., Kuchroo V. J., Sacks D., CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis Journal of Experimental Medicine 2007 204 2 285 297 (Pubitemid 46294545)
59. Murray H. W., Jungbluth A., Ritter E., Montelibano C., Marino M. W., Visceral Leishmaniasis in mice devoid of tumor necrosis factor and response to treatment Infection and Immunity 2000 68 11 6289 6293
60. Tumang M. C., Keogh C., Moldawer L. L., Helfgott D. C., Teitelbaum R., Hariprashad J., Murray H. W., Role and effect of TNF- in experimental visceral leishmaniasis Journal of Immunology 1994 153 2 768 775
61. Liew F. Y., Li Y., Millott S., Tumor necrosis factor- synergizes with IFN- in mediating killing of Leishmania major through the induction of nitric oxide Journal of Immunology 1990 145 12 4306 4310
62. Oghumu S., Lezama-Dvila C. M., Isaac-Mrquez A. P., Satoskar A. R., Role of chemokines in regulation of immunity against leishmaniasis Experimental Parasitology 2010 126 3 389 396
63. Stanley A. C., Engwerda C. R., Balancing immunity and pathology in visceral leishmaniasis Immunology and Cell Biology 2007 85 2 138 147 (Pubitemid 46398719)
64. Teixeira M. J., Teixeira C. R., Andrade B. B., Barral-Netto M., Barral A., Chemokines in host-parasite interactions in leishmaniasis Trends in Parasitology 2006 22 1 32 40 (Pubitemid 43017202)
65. Dey R., Sarkar A., Majumder N., Bhattacharyya S. M., Roychoudhury K., Bhattacharyya S., Roy S., Majumdar S., Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis Infection and Immunity 2005 73 12 8334 8344 (Pubitemid 41740324)
66. Mannheimer S. B., Hariprashad J., Stoeckle M. Y., Murray H. W., Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor FEMS Immunology and Medical Microbiology 1996 14 1 59 61 (Pubitemid 26198380)
67. Harrington L. E., Mangan P. R., Weaver C. T., Expanding the effector CD4 T-cell repertoire: the Th17 lineage Current Opinion in Immunology 2006 18 3 349 356
68. Pitta M. G., Romano A., Cabantous S., Henri S., Hammad A., Kouriba B., Argiro L., El Kheir M., Bucheton B., Mary C., El-Safi S. H., Dessein A., IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani Journal of Clinical Investigation 2009 119 8 2379 2387
69. Ruiz J. H., Becker I., CD8 cytotoxic T cells in cutaneous leishmaniasis Parasite Immunology 2007 29 12 671 678 (Pubitemid 350179394)
70. Polley R., Stager S., Prickett S., Maroof A., Zubairi S., Smith D. F., Kaye P. M., Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen Infection and Immunity 2006 74 1 773 776 (Pubitemid 43023137)
71. Squires K. E., Schreiber R. D., McElrath M. J., Rubin B. Y., Anderson S. L., Murray H. W., Experimental visceral leishmaniasis: role of endogenous IFN- in host defense and tissue granulomatous response Journal of Immunology 1989 143 12 4244 4249 (Pubitemid 20012622)
72. Stager S., Smith D. F., Kaye P. M., Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis Journal of Immunology 2000 165 12 7064 7071 (Pubitemid 32001180)
73. Stern J. J., Oca M. J., Rubin B. Y., Anderson S. L., Murray H. W., Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis Journal of Immunology 1988 140 11 3971 3977
74. Larsen M. H., Biermann K., Chen B., Hsu T., Sambandamurthy V. K., Lackner A. A., Aye P. P., Didier P., Huang D., Shao L., Wei H., Letvin N. L., Frothingham R., Haynes B. F., Chen Z. W., Jacobs W. R., Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates Vaccine 2009 27 34 4709 4717
75. Okwor I., Liu D., Beverley S. M., Uzonna J. E., Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process Proceedings of the National Academy of Sciences of the United States of America 2009 106 33 13951 13956
76. Bhaumik S. K., Singh M. K., Karmakar S., De T., UDP-Gal: N-acetylglucosamine 14 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis Glycoconjugate Journal 2009 26 6 663 673
77. Gorczynski R. M., Immunization of susceptible BALB/c mice against Leishmania braziliensis. I. Resistance induced using as immunogen adherent or nonadherent cells from infected mice Cellular Immunology 1985 94 1 1 10 (Pubitemid 15247790)
78. Mitchell G. F., Handman E., Spithill T. W., Vaccination against cutaneous Leishmaniasis in mice using nonpathogenic cloned promastigotes of leishmania major and importance of route of injection Australian Journal of Experimental Biology and Medical Science 1984 62 2 145 153 (Pubitemid 14058198)
79. Titus R. G., Gueiros-Filho F. J., De Freitas L. A. R., Beverley S. M., Development of a safe live Leishmania vaccine line by gene replacement Proceedings of the National Academy of Sciences of the United States of America 1995 92 22 10267 10271
80. Amaral V. F., Teva A., Oliveira-Neto M. P., Silva A. J., Pereira M. S., Cupolillo E., Porrozzi R., Coutinho S. G., Pirmez C., Beverley S. M., Grimaldi G., Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease Memorias do Instituto Oswaldo Cruz 2002 97 7 1041 1048 (Pubitemid 135747502)
81. Spth G. F., Lye L. F., Segawa H., Sacks D. L., Turco S. J., Beverley S. M., Persistence without pathology in phosphoglycan-deficient Leishmania major Science 2003 301 5637 1241 1243 (Pubitemid 37052214)
82. Uzonna J. E., Spth G. F., Beverley S. M., Scott P., Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response Journal of Immunology 2004 172 6 3793 3797 (Pubitemid 38337964)
83. Spth G. F., Lye L. F., Segawa H., Turco S. J., Beverley S. M., Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies Infection and Immunity 2004 72 6 3622 3627 (Pubitemid 38697791)
84. Kedzierski L., Curtis J. M., Doherty P. C., Handman E., Kedzierska K., Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites European Journal of Immunology 2008 38 11 3090 3100
85. Alexander J., Coombs G. H., Mottram J. C., Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response Journal of Immunology 1998 161 12 6794 6801 (Pubitemid 28562223)
86. Saravia N. G., Escorcia B., Osorio Y., Valderrama L., Brooks D., Arteaga L., Coombs G., Mottram J., Travi B. L., Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models Vaccine 2006 24 19 4247 4259
87. Papadopoulou B., Roy G., Breton M., Kndig C., Dumas C., Fillion I., Singh A. K., Olivier M., Ouellette M., Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination Infection and Immunity 2002 70 1 62 68 (Pubitemid 34028599)
88. Zhang W. W., Matlashewski G., Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection Molecular Microbiology 2001 39 4 935 948 (Pubitemid 32176338)
89. Silvestre R., Cordeiro-Da-Silva A., Santarém N., Vergnes B., Sereno D., Ouaissi A., SIR2-deficient Leishmania infantum induces a defined IFN- /IL-10 pattern that correlates with protection Journal of Immunology 2007 179 5 3161 3170
90. Davoudi N., Tate C. A., Warburton C., Murray A., Mahboudi F., McMaster W. R., Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials Vaccine 2005 23 9 1170 1177 (Pubitemid 40052013)
91. Muyombwe A., Olivier M., Ouellette M., Papadopoulou B., Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene Experimental Parasitology 1997 85 1 35 42 (Pubitemid 27236712)
92. Selvapandiyan A., Duncan R., Debrabant A., Bertholet S., Sreenivas G., Negi N. S., Salotra P., Nakhasi H. L., Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite Journal of Biological Chemistry 2001 276 46 43253 43261
93. Selvapandiyan A., Kumar P., Morris J. C., Salisbury J. L., Wang C. C., Nakhasi H. L., Centrin1 is required for organelle segregation and cytokinesis in Trypanosoma brucei Molecular Biology of the Cell 2007 18 9 3290 3301 (Pubitemid 47378671)
94. Mahajan B., Selvapandiyan A., Gerald N. J., Majam V., Zheng H., Wickramarachchi T., Tiwari J., Fujioka H., Moch J. K., Kumar N., Aravind L., Nakhasi H. L., Kumar S., Centrins, cell cycle regulation proteins in human malaria parasite Plasmodium falciparum Journal of Biological Chemistry 2008 283 46 31871 31883
95. Salisbury J. L., Centrin, centrosomes, and mitotic spindle poles Current Opinion in Cell Biology 1995 7 1 39 45
96. Selvapandiyan A., Debrabant A., Duncan R., Muller J., Salotra P., Sreenivas G., Salisbury J. L., Nakhasi H. L., Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania Journal of Biological Chemistry 2004 279 24 25703 25710 (Pubitemid 38756834)
97. Dey R., Meneses C., Salotra P., Kamhawi S., Nakhasi H. L., Duncan R., Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence Molecular Microbiology 2010 77 2 399 414
98. Mizbani A., Taheri T., Zahedifard F., Taslimi Y., Azizi H., Azadmanesh K., Papadopoulou B., Rafati S., Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis Vaccine 2009 28 1 53 62
99. Duncan R., Dey R., Tomioka K., Biomarkers of attenuation in the Leishmania donovani centrin gene deleted cell line-requirements for safety in a live vaccine candidate The Open Parasitology Journal 2009 3 32 41
100. Srividya G., Duncan R., Sharma P., Raju B. V. S., Nakhasi H. L., Salotra P., Transcriptome analysis during the process of in vitro differentiation of Leishmania donovani using genomic microarrays Parasitology 2007 134 11 1527 1539 (Pubitemid 350194877)
101. Duncan R. C., Salotra P., Goyal N., Akopyants N. S., Beverley S. M., Nakhasi H. L., The application of gene expression microarray technology to kinetoplastid research Current Molecular Medicine 2004 4 6 611 621 (Pubitemid 39172367)
102. McCarthy-Burke C., Bates P. A., Dwyer D. M., Leishmania donovani: use of two different, commercially available, chemically defined media for the continuous in vitro cultivation of promastigotes Experimental Parasitology 1991 73 3 385 387
103. Akopyants N. S., Kimblin N., Secundino N., Patrick R., Peters N., Lawyer P., Dobson D. E., Beverley S. M., Sacks D. L., Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector Science 2009 324 5924 265 268
104. Zaph C., Uzonna J., Beverley S. M., Scott P., Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites Nature Medicine 2004 10 10 1104 1110 (Pubitemid 39424872)
105. Kaech S. M., Wherry E. J., Ahmed R., Effector and memory T-cell differentiation: implications for vaccine development Nature Reviews Immunology 2002 2 4 251 262 (Pubitemid 37323225)
106. Nieto A., Dominguez-Bernal G., Orden J. A., Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model Veterinary Research 2011 42 1 39
107. Olobo J. O., Gicheru M. M., Anjili C. O., The African Green monkey model for cutaneous and visceral leishmaniasis Trends in Parasitology 2001 17 12 588 592 (Pubitemid 34088119)
108. Garg R., Dube A., Animal models for vaccine studies for visceral leishmaniasis Indian Journal of Medical Research 2006 123 3 439 454 (Pubitemid 43905581)
109. Binhazim A. A., Githure J. I., Muchemi G. K., Reid G. D. F., Isolation of Leishmania major from a naturally infected vervet monkey (Cercopithecus aethiops) caught in Kiambu district, Kenya Journal of Parasitology 1987 73 6 1278 1279 (Pubitemid 18073732)
110. Githure J. I., Reid G. D. F., Binhazim A. A., Anjili C. O., Shatry A. M., Hendricks L. D., Leishmania major: the suitability of East African nonhuman primates as animal models for cutaneous leishmaniasis Experimental Parasitology 1987 64 3 438 447 (Pubitemid 18012342)
111. Lawyer P. G., Githure J. I., Anjili C. O., Olobo J. O., Koech D. K., Reid G. D. F., Experimental transmission of Leishmania major to vervet monkeys (Cercopithecus aethiops) by bites of Phlebotomus duboscqi (Diptera: Psychodidae) Transactions of the Royal Society of Tropical Medicine and Hygiene 1990 84 2 229 232 (Pubitemid 20172012)
112. Hailu A., Negesse Y., Abraham I., Leishmania aethiopica: experimental infections in non-human primates Acta Tropica 1995 59 3 243 250
113. Binhazim A. A., Shin S. S., Chapman W. L., Olobo J., Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum Laboratory Animal Science 1993 43 1 37 47 (Pubitemid 23075438)
114. Anuradha, Pal R., Zehra K., Katiyar J. C., Sethi N., Bhatia G., Singh R. K., The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis Bulletin of the World Health Organization 1992 70 1 63 72
115. Dennis V. A., Chapman W. L. Jr., Hanson W. L., Lujan R., Leishmania donovani: clinical, hematologic and hepatic changes in squirrel monkeys (Saimiri sciureus) Journal of Parasitology 1985 71 5 576 582 (Pubitemid 16234592)
116. Lujan R., Chapman W. L. Jr., Hanson W. L., Dennis V. A., Leishmania braziliensis: development of primary and satellite lesions in the experimentally infected owl monkey, Aotus trivirgatus Experimental Parasitology 1986 61 3 348 358 (Pubitemid 16069847)
117. Cuba C. A., Ferreira V., Bampi M., Magalhes A., Marsden P. D., Vexenat A., De Mello M. T., Experimental infection with Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the marmoset, Callithrix penicillata (Primates:Callithricidae) Memorias do Instituto Oswaldo Cruz 1990 85 4 459 467
118. Freidag B. L., Mendez S., Cheever A. W., Kenney R. T., Flynn B., Sacks D. L., Seder R. A., Immunological and pathological evaluation of rhesus macaques infected with Leishmania major Experimental Parasitology 2003 103 3-4 160 168 (Pubitemid 36918191)
119. Ansari N. A., Ramesh V., Salotra P., Interferon (IFN)-, tumor necrosis factor-, interleukin-6, and IFN- receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis Journal of Infectious Diseases 2006 194 7 958 965 (Pubitemid 44454081)
120. Garg R., Gupta S. K., Tripathi P., Hajela K., Sundar S., Naik S., Dube A., Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis Vaccine 2006 24 15 2900 2909
121. Tripathi P., Ray S., Sunder S., Dube A., Naik S., Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals Clinical and Experimental Immunology 2006 143 2 380 388
122. Meddeb-Garnaoui A., Toumi A., Ghelis H., Mahjoub M., Louzir H., Chenik M., Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively Vaccine 2010 28 7 1881 1886
123. Reis L. C., Brito M. E. F., Souza M. A., Medeiros A. C. R., Silva C. J., Luna C. F., Pereira V. R. A., Cellular immune response profile in patients with american tegumentary leishmaniasis prior and post chemotherapy treatment Journal of Clinical Laboratory Analysis 2009 23 1 63 69
124. Ajdary S., Riazi-Rad F., Alimohammadian M. H., Pakzad S. R., Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis Journal of Infection 2009 59 2 139 143
125. Kurtzhals J. A.L., Kemp M., Poulsen L. K., Hansen M. B., Kharazmi A., Theander T. G., Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals Scandinavian Journal of Immunology 1995 41 4 343 349
126. Rodrigues C. A. T., Batista L. F. D. S., Filho R. S. T., Santos C. D. S., Pinheiro C. G., Almeida T. F. D., Freitas L. A. R. D., Veras P. S. T., IFN- expression is up-regulated by peripheral blood mononuclear cells (PBMC) from non-exposed dogs upon Leishmania chagasi promastigote stimulation in vitro Veterinary Immunology and Immunopathology 2009 127 3-4 382 388
127. Basu R., Roy S., Walden P., HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages Journal of Infectious Diseases 2007 195 9 1373 1380 (Pubitemid 46649626)
128. Belkaid Y., Kamhawi S., Modi G., Valenzuela J., Noben-Trauth N., Rowton E., Ribeiro J., Sacks D. L., Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis Journal of Experimental Medicine 1998 188 10 1941 1953 (Pubitemid 28536781)
129. Kaur S., Kaur T., Garg N., Mukherjee S., Raina P., Athokpam V., Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis Parasitology Research 2008 103 6 1413 1419
130. Streit J. A., Recker T. J., Gueiros Filho F., Beverley S. M., Wilson M. E., Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms Journal of Immunology 2001 166 3 1921 1929 (Pubitemid 32114679)
131. Collin N., Gomes R., Teixeira C., Cheng L., Laughinghouse A., Ward J. M., Elnaiem D. -E., Fischer L., Valenzuela J. G., Kamhawi S., Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania PLoS Pathogens 2009 5 5
132. Theodos C. M., Ribeiro J. M. C., Titus R. G., Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice Infection and Immunity 1991 59 5 1592 1598
133. Peters N. C., Kimblin N., Secundino N., Kamhawi S., Lawyer P., Sacks D. L., Vector transmission of Leishmania abrogates vaccine-induced protective immunity PLoS Pathogens 2009 5 6